Filtered By:
Condition: Obesity
This page shows you your search results in order of date. This is page number 19.
Order by Relevance | Date
Total 3042 results found since Jan 2013.
COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations
World J Hepatol. 2023 Apr 27;15(4):441-459. doi: 10.4254/wjh.v15.i4.441.ABSTRACTThe coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 is an ongoing health concern. In addition to affecting the respiratory system, COVID-19 can potentially damage other systems in the body, leading to extra-pulmonary manifestations. Hepatic manifestations are among the common consequences of COVID-19. Although the precise mechanism of liver injury is still questionable, several mechanisms have been hypothesized, including direct viral effect, cytokine storm, hypoxic-ischemic injury, hypoxia-reperfus...
Source: World Journal of Hepatology - May 19, 2023 Category: Gastroenterology Authors: Romina Roshanshad Amirhossein Roshanshad Reza Fereidooni Mahnaz Hosseini-Bensenjan Source Type: research
Prevalence of persistent symptoms after having COVID-19 in a cohort in Suriname
CONCLUSIONS: About 40% of the cohort had at least one persistent symptom 3-4 months after having had COVID-19, with differences observed by sex and ethnic group.PMID:37197595 | PMC:PMC10184584 | DOI:10.26633/RPSP.2023.79
Source: Pan American Journal of Public Health - May 17, 2023 Category: International Medicine & Public Health Authors: Ingrid Krishnadath Soeradj Harkisoen Fitzgerald Gopie Kwame van der Hilst Michelle Hollum Lycke Woittiez Se-Sergio Baldew Source Type: research
Outcomes of cancer patients with COVID-19: the Virginia Commonwealth University experience
CONCLUSION: The mortality rate of cancer patients was 10.5%, lower than other studies. Vaccinations had mortality benefit, but no effect on hypoxia, ventilator use, or LOS. Delaying cancer therapy during peak infection is likely not necessary based on results of this study. With improved knowledge in the risks of infection and utility of personalized precautions, both providers and patients can better prepare for another potential wave of COVID-19.PMID:37194996 | DOI:10.1080/07357907.2023.2215325
Source: Cancer Investigation - May 17, 2023 Category: Cancer & Oncology Authors: Patrick J Willard Yiwei Hang Temitayo Olasehinde Naji Bou Zeid Edem Defor Dipankar Bandyopadhyay Victor Yazbeck Source Type: research
Prevalence of persistent symptoms after having COVID-19 in a cohort in Suriname
CONCLUSIONS: About 40% of the cohort had at least one persistent symptom 3-4 months after having had COVID-19, with differences observed by sex and ethnic group.PMID:37197595 | PMC:PMC10184584 | DOI:10.26633/RPSP.2023.79
Source: Pan American Journal of Public Health - May 17, 2023 Category: International Medicine & Public Health Authors: Ingrid Krishnadath Soeradj Harkisoen Fitzgerald Gopie Kwame van der Hilst Michelle Hollum Lycke Woittiez Se-Sergio Baldew Source Type: research
Outcomes of cancer patients with COVID-19: the Virginia Commonwealth University experience
CONCLUSION: The mortality rate of cancer patients was 10.5%, lower than other studies. Vaccinations had mortality benefit, but no effect on hypoxia, ventilator use, or LOS. Delaying cancer therapy during peak infection is likely not necessary based on results of this study. With improved knowledge in the risks of infection and utility of personalized precautions, both providers and patients can better prepare for another potential wave of COVID-19.PMID:37194996 | DOI:10.1080/07357907.2023.2215325
Source: Cancer Investigation - May 17, 2023 Category: Cancer & Oncology Authors: Patrick J Willard Yiwei Hang Temitayo Olasehinde Naji Bou Zeid Edem Defor Dipankar Bandyopadhyay Victor Yazbeck Source Type: research
Prevalence of persistent symptoms after having COVID-19 in a cohort in Suriname
CONCLUSIONS: About 40% of the cohort had at least one persistent symptom 3-4 months after having had COVID-19, with differences observed by sex and ethnic group.PMID:37197595 | PMC:PMC10184584 | DOI:10.26633/RPSP.2023.79
Source: Pan American Journal of Public Health - May 17, 2023 Category: International Medicine & Public Health Authors: Ingrid Krishnadath Soeradj Harkisoen Fitzgerald Gopie Kwame van der Hilst Michelle Hollum Lycke Woittiez Se-Sergio Baldew Source Type: research
Outcomes of cancer patients with COVID-19: the Virginia Commonwealth University experience
CONCLUSION: The mortality rate of cancer patients was 10.5%, lower than other studies. Vaccinations had mortality benefit, but no effect on hypoxia, ventilator use, or LOS. Delaying cancer therapy during peak infection is likely not necessary based on results of this study. With improved knowledge in the risks of infection and utility of personalized precautions, both providers and patients can better prepare for another potential wave of COVID-19.PMID:37194996 | DOI:10.1080/07357907.2023.2215325
Source: Cancer Investigation - May 17, 2023 Category: Cancer & Oncology Authors: Patrick J Willard Yiwei Hang Temitayo Olasehinde Naji Bou Zeid Edem Defor Dipankar Bandyopadhyay Victor Yazbeck Source Type: research
Prevalence of persistent symptoms after having COVID-19 in a cohort in Suriname
CONCLUSIONS: About 40% of the cohort had at least one persistent symptom 3-4 months after having had COVID-19, with differences observed by sex and ethnic group.PMID:37197595 | PMC:PMC10184584 | DOI:10.26633/RPSP.2023.79
Source: Pan American Journal of Public Health - May 17, 2023 Category: International Medicine & Public Health Authors: Ingrid Krishnadath Soeradj Harkisoen Fitzgerald Gopie Kwame van der Hilst Michelle Hollum Lycke Woittiez Se-Sergio Baldew Source Type: research
